Loading chat...
OK SCR62
Concurrent Resolution
Status
5/25/2010
Primary Sponsor
Michael Schwartz
Click for details
AI Summary
-
Encourages the Medicaid Drug Utilization Review Board within the Oklahoma Health Care Authority to amend the prior authorization program for atypical antipsychotic medications.
-
Current program requires patients to trial one Tier One drug and all Tier Two drugs before accessing Tier Three medications; resolution seeks to reduce this to one drug per tier.
-
Addresses concerns that delaying access to more effective medications could negatively impact individuals with serious psychiatric conditions like schizophrenia, acute mania, and bipolar disorder.
-
Directs the Secretary of State to distribute the resolution to the Oklahoma Health Care Authority Board.
Legislative Description
Public health; encouraging the Oklahoma Health Care Authority to amend prior authorization program.
Health Care
Last Action
Introduced
5/25/2010